2006
DOI: 10.1016/j.ophtha.2006.04.034
|View full text |Cite
|
Sign up to set email alerts
|

Recurrence of Amblyopia after Occlusion Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
77
0
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 103 publications
(80 citation statements)
references
References 11 publications
2
77
0
1
Order By: Relevance
“…Conventional amblyopia treatment emphasizes patching or penalization of the fellow-fixing (non-amblyopic) eye to force the use of the amblyopic eye [4][5][6]. While effective at improving visual acuity [6,7], current treatment is often associated with residual monocular [8] and binocular [9] deficits, and a high rate of recurrence [10]. It has been argued that the monocular treatment approach may not be maximally effective, as it does not directly address suppression [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…Conventional amblyopia treatment emphasizes patching or penalization of the fellow-fixing (non-amblyopic) eye to force the use of the amblyopic eye [4][5][6]. While effective at improving visual acuity [6,7], current treatment is often associated with residual monocular [8] and binocular [9] deficits, and a high rate of recurrence [10]. It has been argued that the monocular treatment approach may not be maximally effective, as it does not directly address suppression [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…Typically, patients with mild to moderate amblyopia are prescribed complete occlusion for 2-6 waking hours per day, over several months to more than a year (Pediatric Eye Disease Investigator Group 2003a,b; Repka et al 2003;Stewart et al 2004Stewart et al , 2006. Patients with moderate to severe amblyopia are often prescribed 6-10 h or more than a day (Pediatric Eye Disease Investigator Group 2003a,b), and some clinicians recommend more aggressive full-time occlusion for severe amblyopia (Dorey et al 2001;Bhola et al 2006;Stankovic & Milenkovic 2007). As reported in a recent large-scale clinical study of children (3-8 years of age), the dose-response rate for occlusion is approximately 0.1 log unit (1 chart line) per 120 h of occlusion, and the treatment efficacy is 3-4 logMAR lines (Stewart et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Recurrence in amblyopia was noted in 7% to 27%, with a low reported recurrence in children who underwent treatment after the age of 7 years 49 . Age of the child at the cessation of treatment does appear to be a factor, with recurrence inversely correlated with patient age 46 .…”
Section: Recurrence Of Amblyopia Following Therapymentioning
confidence: 95%
“…Some recent studies have sought to identify factors which may influence whether recurrence is likely to occur [46][47][48][49] . These include; age of termination of treatment; VA at the time of cessation of treatment; and which type of amblyopia is present.…”
Section: Recurrence Of Amblyopia Following Therapymentioning
confidence: 99%